Abstract
Changes in Hemoglobin Measures Observed in PNH Patients Treated with Both C5 Inhibitors Ravulizumab and Eculizumab: Real-World Evidence from a US-Based EMR Network
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have